Background: Gender-related biases in outcomes after thoracic aortic surgery are an important factor to consider in the prevention of potential complications related to aortic diseases and in the analysis of surgical results. Methods: The aim of this study is to provide an up-to-date review of gender-related differences in the epidemiology, specific risk factors, outcome, and screening and prevention programmes in aortic aneurysms. Results: Female patients affected by aortic disease still have worse outcomes and higher early and late mortality than men. It is difficult to plan new specific strategies to improve outcomes in women undergoing major aortic surgery, given that the true explanations for their poorer outcomes are as yet not clearly identified. Some authors recommend further investigation of hormonal or molecular explanations for the sex differences in aortic disease. Others stress the need for quality improvement projects to quantify the preoperative risk in high-risk populations using non-invasive tests such as cardiopulmonary exercise testing. Conclusions: The treatment of patients classified as high risk could thus be optimised before surgery becomes necessary by means of numerous strategies, such as the administration of high-dose statin therapy, antiplatelet treatment, optimal control of hypertension, lifestyle improvement with smoking cessation, weight loss and careful control of diabetes. Future efforts are needed to understand better the gender differences in the diagnosis, management and outcome of aortic aneurysm disease, and for appropriate and modern management of female patients.
Introduction
It is well established that cardiovascular disease (CVD) is the main cause of death in the USA and European Community. 1, 2 In particular, it has been estimated that the disease of the aorta and its major vessels is responsible for 43,000-47,000 deaths per year. 3 It is well known that men suffer aortic disease more frequently than women, with varying proportions reported in different studies, although results are worse in women. Thoracic aortic disease includes a wide spectrum of clinical presentations and it is usually classified into abdominal aortic aneurysms (AAAs), thoracic aortic aneurysms (TAAs) and aortic dissections. According to this classification, gender distribution presents significant differences, with a higher ratio of men to women, ranging from approximately 2 to 5:1 for AAAs, and approximately 1.7:1 for TAAs. [4] [5] [6] Gender-related biases in outcomes after thoracic aortic surgery are an important factor to consider in the prevention of potential complications related to aortic diseases and in the analysis of surgical results. However, explanations for these differences remain to be addressed. In fact, women are under-represented in clinical trials and studies; 7 moreover, difficulties of interpretation arise from the complex pathophysiology of aortic diseases, including degenerative, structural, genetic and traumatic aetiology; and finally there are no studies to indicate gender differences in the histopathology of aortic diseases.
The aim of this study is to provide an up-to-date review of gender-related differences in the epidemiology, specific risk factors, outcome, and screening and prevention programmes in aortic aneurysms.
Methods

Literature search and eligibility criteria
The topic is not presented in the form of a systematic review. A comprehensive review of Embase, Medline, Cochrane Library and Pubmed (including articles published ahead of print) databases was performed using various combinations of medical subject heading terms 'abdominal', 'thoracic', 'thoracoabdominal', 'growth', 'dilation', 'expansion', 'aorta' and 'aneurysm', 'gender', 'female', 'male', with Boolean operators 'AND' or 'OR' without filters. To reflect contemporary management of this pathology in view of the large differences in risk and outcome we considered articles published from 1 January 1990 to date.
Study selection
All studies were read and assessed for quality by two independent authors (RG and TM). Discrepancies were solved by repeated review and discussion.
Abdominal aortic aneurysms Epidemiology and risk factors
Major differences between men and women have been reported in the epidemiology, pathophysiology, treatment and outcome of CVDs, such as coronary artery disease (CAD), hypertension, cardiomyopathy, and heart failure. 8 In fact, men develop CAD and consequent myocardial infarction earlier and usually present with more severe atherosclerosis in their coronary arteries than women. Moreover men suffer frequently from occlusive CAD, while women more frequently experience a non-obstructive CAD or microvascular dysfunction. CAD may be located in the epicardial coronary arteries, as a consequence of atherosclerosis, more commonly in men, and characterised by pathological vasoreactivity, such as spasm and endothelial dysfunction, more commonly in women, as spontaneous coronary artery dissection and the Takotsubo syndrome. It is also well known that the number of hypertensive individuals in younger age groups is greater in the male population than in the female population, unlike the elderly, in whom the percentage of hypertensive women is double the numbers of men. Sex differences in hypertension seem to be related to the renin-angiotensin system and the bradykinin and nitric oxide system.
Moreover, sex differences have been described in glucose homeostasis, prediabetic syndromes, and type 1 and type 2 diabetes. 9 Sex hormones play a role, at least partially, in these gender differences. In fact, type 1 diabetes is the only common autoimmune disease not characterised by female predominance and exhibits an increased male bias after puberty. It is demonstrated that oestrogen deficiency and/or testosterone excess predisposes women to type 2 diabetes, whereas testosterone deficiency predisposes men to type 2 diabetes.
In the field of vascular pathology, gender differences have been particularly studied in AAA disease. [10] [11] [12] It is well known that female sex, current smoking, and high mean arterial pressure 13 have been identified as risk factors for AAA rupture. Moreover, patient age and low body mass index have been indicated as additional risk factors in a large meta-analysis, 14 and the body surface area-adjusted diameter has been recommended as an improving parameter of evaluation of the standard diameter for female patients with AAAs. 15 Significantly, women with AAAs are older at time of surgery, have more rapidly growing aneurysms, and have a significantly higher rupture risk than men, including at smaller diameters. 12, [16] [17] [18] Several epidemiological studies on the subject have been published. A study from Sweden reported an incidence of 5.6 per 100,000 person-years for ruptured AAAs in a 16-year period (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) , with a significant difference between the sexes: 8.4/100,000 for men and 3/100,000 women. 4 Katz et al. 19 reviewed more than 47,000 admissions for AAA collected in the Michigan Inpatient Database during a 10-year period. They found AAAs to be more common in men, with a 5:1 prevalence. Women presented with AAAs, both intact and ruptured, approximately 10 years later than men, probably because the postmenopausal state discontinues the potentially protective effect of oestrogen blood levels. In fact, differences in the hormonal condition result in delayed presentation of AAAs in women, different degrees of atherosclerosis and different matrix metalloproteinase production. 20 Other possible explanations have been advanced for the differences in clinical presentation and outcomes between the sexes. For example, an aneurysm of a certain diameter in a woman can represent more advanced disease than the same-sized aneurysm in a man, given the smaller body size of women. 21 Moreover, it is well documented that women have a higher rate of undiagnosed and untreated CVD. 22, 23 Finally, the vascular anatomy of women, often characterised by small and tortuous arteries with more angulated infrarenal necks 24 and small iliac arteries, [25] [26] [27] may limit their eligibility for the less invasive endovascular aneurysm repair (EVAR), and leave them more susceptible to vessel injury and procedural complications, even when treated. 28 
Results of traditional open surgery
A large amount of scientific evidence shows that women have worse outcomes for elective and emergent surgical repair of AAAs, 11, 12, 29 even after adjustment for age and comorbidities. [30] [31] [32] Sidloff et al. 33 recently published a study comparing mortality following AAA repair between men and women in the United Kingdom. The primary outcome was inhospital mortality, and secondary outcome measures were 5-year mortality stratified by age group and hospital stay duration. Women were 13% of a total 23,245 patient population. Women had open surgery repair more frequently than men. For the elective open AAA repair subgroup, the inhospital mortality rate was 6.9% in women and 4.0% in men (P ¼ 0.014), whereas for elective endovascular AAA repair it was 1.8% in women and 0.7% in men (P < 0.001). For the ruptured open AAA repair subgroup, the inhospital mortality rate was higher in women (33.6% vs. 27.1%; P < 0.001). The authors found that the excess mortality risk in elective AAA repair was largely independent of age, aneurysm diameter, smoking status and timing of surgery. Furthermore, sex differences were confirmed after adjustment for comorbidities made with sensitivity analysis, mostly after elective EVAR. Mehta et al. 34 also demonstrated a significantly greater risk of death in women than men after an elective EVAR procedure, but no sex difference was found among patients undergoing open repair in this series. An analysis of data from the American College of Surgeons National Surgical Improvement Program (2011 Program ( -2014 recently demonstrated that women undergoing elective AAA repair were older, had smaller aneurysms, and had a significantly higher 30-day mortality rate after EVAR and open AAA repair. 35 Taken together, these studies confirm the higher postoperative risk for women, including after elective AAA repair.
On the other hand Lo et al., 36 using the Vascular Study Group of New England database to identify all patients undergoing EVAR or open AAA repair, analysed demographics, comorbidities, and procedural and perioperative data of 4026 patients (78% men) who underwent AAA repair (54% EVAR). The authors found that women underwent EVAR less frequently than men for intact aneurysms (50% vs. 60% of intact AAA repair; P < 0.001) but not for ruptured aneurysms (26% vs. 20%; P ¼ 0.23). Among patients undergoing open repair for intact aneurysms, women more frequently experienced severe postoperative morbidity including leg ischaemia/emboli and bowel ischaemia. Women had a higher 30-day mortality after open aortic repair for intact and rupture repairs. However, the 30-day mortality after EVAR was similar for intact and rupture repairs. Late survival was worse in women than men only for patients undergoing open repair of ruptured aneurysms. According to other studies, women with AAAs present at surgery at older ages and smaller AAA diameters, and tend to undergo rupture repair at smaller diameters than men. Age over 80 years, comorbidity, presentation and type of repair are more important predictors of mortality than gender. In fact, although women are more likely to experience perioperative complications as a result of less favourable vascular anatomy, after controlling for age, type of repair, urgency at presentation (i.e. elective/intact vs. ruptured), comorbidities and other relevant risk factors, the authors found that gender was not predictive of 30-day or 1-year mortality in the study.
Results of endovascular treatment
Interestingly, this gender-related increased morbidity and mortality has also been reported in patients who have EVAR. 31 McPhee et al. 12 analysed the nationwide inpatient sample for 2001-2004, and found that women had higher overall mortality for intact AAAs, 4.8% versus 2.6% (P < 0.001), treated with both open and endovascular procedures. Women were also less likely to undergo EVAR for intact AAA repair than men, 32.4% versus 46.7% (P < 0.001), because of their unfavourable anatomy for EVAR. Several studies [25] [26] 28 have shown that women have decreased neck length, more angulated infrarenal necks and narrow iliac access, even after adjustment for other variables such as age and aneurysm size. Moreover, after EVAR treatment, women experienced higher rates of intraoperative complications, longer intensive care unit stays and higher rates of bowel ischaemia and complications requiring a return to the operating room, as described by Abedi et al. 31 
New hypotheses on gender differences
Several studies have recently been published regarding new hypotheses and suggestions explaining these differences in presentation and outcomes between men and women.
Ailawadi et al. 20 investigated the potential for a molecular-based gender difference and reported evidence that gender differences in AAA development could be related to an oestrogen-mediated reduction in matrix metalloproteinase-9 production. Villard et al. 37 studied the differential expression of sex hormone receptors in AAAs, on the basis that female sex hormones have been shown to prevent aneurysm formation in animal models. The authors compared the expression profile of sex hormone receptors in the aneurysm wall biopsies of men and women with controls from organ donation. They found that expression of sex hormone receptors differs in the aneurysmal aorta compared with control samples in men and women. In particular, a higher expression of androgen receptor and a lower expression of oestrogen receptor in AAAs compared with control aorta suggest an association between sex hormone activity and aneurysm development.
Taylor et al. 38 focused on the role of local abdominal haemodynamic forces on the vascular wall. In particular the authors hypothesised that oscillatory shear stress is a specific signal to the endothelium, which initiates the events leading to AAA formation, and that sex-dependent differences in oscillatory shear stress in the infrarenal aorta may explain the gender-related differences. Ye et al. 39 investigated the potential influence of genetic variants on susceptibility to AAAs (CDKN2A-2B, SORT1, DAB2IP, LRP1 and LDLR), and their association (particularly gender-related) with AAA expansion. In a population of 650 patients affected by AAA, the authors demonstrated that women had a mean greater aneurysm expansion than men after adjustment for baseline AAA diameter. Moreover, they demonstrated that variants DAB2IP-rs7025486[A] and SORT1-rs599839[G] are associated with AAA expansion. In particular, the association of rs7025486[A] is stronger in women than in men and is amplified by high pulse pressure, explaining in part the described sex differences in aneurysm expansion. These results highlight the utility of risk stratification by this single nucleotide polymorphism in women, and that specific pharmacological therapy aimed at arterial destiffening limiting aneurysm expansion may have a favourable impact in women. van de Luijtgaarden et al. 40 studied the gender-related genetic predisposition to aneurysm disease. The authors recently investigated the familial risk of AAAs for women compared to men in all living AAA patients included in a 2004-2012 prospective database. All these patients were invited to the multidisciplinary vascular/genetics outpatient clinic between 2009 and 2012 in order to assess family history using a detailed questionnaire. The authors found that the risk of aortic aneurysm in relatives of AAA patients is higher than expected from the population risk. Moreover, the excess risk is highest for the female relatives of AAA patients and for the relatives of female AAA patients. These findings emphasise the need for targeted AAA family screening for female and male relatives of all AAA patients (Table 1) .
Thoracic aortic aneurysms Epidemiology and risk factors
TAAs are described as 'silent killers' because they are associated with high morbidity and mortality, although they are rarely symptomatic. 41 TAAs are still understudied in comparison with other CVDs.
The incidence is approximately 10.4 cases per 100,000 person-years. 42 Almost 22% of people who have an acute aortic syndrome die at home before receiving the first medical treatment, 43, 44 and 34% of patients who reach hospital alive die within the first 30 days. 43 The most recognised risk factor for TAA rupture remains aneurysm size. The risk of aortic Table 1 . Gender and abdominal aortic aneurysms.
Highlights
Women with abdominal aortic aneurysms are older at time of surgery, have more rapid growing aneurysms, and have a significantly higher rupture risk than men, including at smaller diameters. Gender-related increased morbidity and mortality has also been reported in patients who have EVAR. Women were also less likely to undergo EVAR for intact AAAs repair than men, 32.4% versus 46.7% (P < 0.001), because of the unfavourable anatomy for EVAR. New hypotheses on gender differences involve: 1. Oestrogen-mediated reduction in matrix metalloproteinase-9 production. 2. Higher expression of androgen receptor and a lower expression of oestrogen receptor in abdominal aortic aneurysm compared with control aorta. 3. Sex-dependent differences in oscillatory shear stress in the infrarenal aorta. 4. Potential influence of genetic variants on susceptibility to abdominal aortic aneurysm (CDKN2A-2B, SORT1, DAB2IP, LRP1 and LDLR), and their association (particularly genderrelated) with aneurysm expansion.
AAA: abdominal aortic aneurysm; EVAR: endovascular aneurysm repair.
rupture is 2% per year for aneurysms smaller than 55 mm diameter, but it is more than 7% in the case of a diameter larger than 6 cm. 45 Patients with TAAs tend less frequently to have a history of smoking, associated CAD, chronic lung disease and diabetes than patients affected by AAAs. 46 The differences in risk profile may reflect a different role played by atherosclerosis in the pathogenetic mechanism of TAA development. In fact, most thoracic aneurysms are associated with degenerative disease resulting in dilation of the aorta. Medial wall degeneration (also known as cystic medial necrosis) is characterised by a fragmented and reduced number of elastic fibres, increased accumulation of proteoglycans and loss of smooth muscle cells. These features lead to the development of TAAs.
A degenerative aneurysm is generally detected in the sixth and seventh decade of life, with women typically older than men. However, it has been found that TAAs are more prevalent in men, although the prognosis is worse in women, 43 in terms of the severe incidence of dissection or rupture 47 and significantly higher mortality, even at a smaller diameter. 48 Moreover, men are more likely to undergo TAA repair for intact aneurysms by EVAR than women, with the same trend observed for AAAs, although without any conclusive explanation. 49 
Results of traditional open surgery
Several studies have been published with the aim of investigating gender-specific differences in outcome after open surgical repair of TAAs.
Beller et al. 50 reported their retrospective study conducted in 548 patients operated with ascending aortic aneurysm surgery and found that the outcome is less favourable in women. Women were reported to have significantly reduced long-term survival and a trend to increased 30-day mortality. The authors argued that the differences between the sexes can be explained by larger normalised aortic diameters, higher incidence of involvement of the aortic arch and differences in comorbidities found in women. Moreover, they confirmed that women presented to surgery at a higher age and with more severe aortic disease. Therefore, the authors concluded that gender-specific guidelines for ascending replacement may be useful to improve outcomes in women. Cheung et al. 51 sought to determine the role of sex and aneurysm aetiology on TAA growth in 82 consecutive unoperated patients who underwent serial aneurysm measurements. The aneurysm growth rate was faster in women than in men (1.19 AE 1.15 mm/year vs. 0.59 AE 0.66 mm/year; P ¼ 0.02), and this trend was also confirmed by multivariable analyses. Interestingly, female sex was associated with faster TAA growth only among patients affected by degenerative TAA and not among those with inheritance variants.
Results of the open surgical repair of TAAs and thoracoabdominal aortic aneurysms are weighted by high mortality and complication rates when compared to other cardiovascular procedures, also in high volume institutions in the United States and Europe.
The risk of increased mortality is related to potential spinal cord ischaemia and renal failure, which are still the two most worrying complications after these procedures. It was reported that the mortality rate was approximately 10% for intact TAAs and 45% for ruptured TAAs, in a study based on the Inpatient Sample Database in the United States from 1988 to 2003. 52 In another study based on 300 patients undergoing open surgical repair for TAAs, 34% were women and 38% had chronic dissection. In this population the authors reported that the inhospital mortality was 8% and 5-year mortality was 64%, with incidence of spinal cord ischaemia of 2.3% and renal failure of 4.2%. Independent predictors for early mortality were female gender and preoperative renal insufficiency. 53 Clouse et al. 54 analysed the results of 333 patients undergoing TAA repair over a 15-year period. The authors showed a 10% rate of late aortic events at an average of 30 months after the index procedure. Again female gender, emergency surgery and unresected disease were independently associated with a higher risk of late event occurrence. Considering that a significant proportion of TAA aneurysm repairs are performed in women, the authors stressed the need for improving postoperative surveillance in this group to prevent late aortic events. Spiliotopoulos et al. 55 investigated whether gender affects outcomes after open thoracoabdominal aortic aneurysm repair in a population of 3353 consecutive patients (1281 women, 38.2%). Men had a significantly higher prevalence of concomitant CAD, and presented more often with dissection; on the other hand, women were older than men at the time of surgery and were more frequently symptomatic. Men were more likely to receive extent II and IV repairs, whereas women more often had extent I and III repairs. The authors found that increasing age, increasing aortic clamp time, the use of hypothermic circulatory arrest and rupture were predictive of adverse events in both sexes. Interestingly, the authors reported sex-specific predictors of adverse events. Chronic renal insufficiency, previous stroke, urgent or emergency repair, and prior open aortic repair were predictive only in men, whereas previous coronary artery bypass grafting, previous open proximal aortic repair and use of a reverse elephant trunk approach were predictive only in women. Finally, the authors studied all the factors predictive of operative mortality and found that increasing age, increasing aortic clamp time and rupture were predictive in both men and women. There are also sex-specific predictors for operative mortality, including urgent or emergency repair, chronic renal insufficiency and previous stroke for men, whereas the presence of any symptoms or having an extent II or III TAA repair, aneurysm without dissection, prior open distal aortic repair, and a history of chronic obstructive pulmonary disease, emphysema, or bronchitis proved to be significant risk factors in women.
Results of endovascular treatment
Gender-related outcome after thoracic endovascular aortic aneurysm repair (TEVAR) is controversial. The first limitation that makes patients unsuitable for TEVAR is an unfavourable anatomy, commonly due to a not adequately proximal neck. A review of 93 patients considered for TEVAR found 26% of patients unsuitable for the endovascular approach for anatomical reasons. The authors did not find any gender difference, although it is well known that women have a tendency to have arterial anatomy more difficult for access than men. 56 Data from three non-randomised multicentre trials showed that the 30-day mortality rate ranged from 1.5% to 2.1%. [57] [58] [59] The most common complications after TEVAR proved to be femoral artery access complications, stroke and paraplegia/paraparesis. Women accounted for about 30% of the population enrolled in all these trials. Interestingly, female gender proved to be predictive of mortality or complications only in a database review of the Gore Pivotal Trial. Other important findings were that women had a longer procedure time for both endovascular and open approaches, which probably explains the well-known incidence of increased complications in the female endovascular group. Moreover, Smith et al. 60 evaluated the results of more complicated repairs with hybrid procedures involving TAA endovascular repair combined with visceral and renal bypasses, but they found no differences in outcome between the genders. Different results have recently been reported by Deery et al., 61 who conducted a retrospective review of all TEVARs in the Society for Vascular Surgery vascular quality initiative registry from 2011 to 2015. The authors studied the results of TEVAR in 2574 patients (40% women), excluding those with dissection, trauma and rupture. Women were older, were more frequently not white and had smaller aortic diameters but larger aortic size indices (aortic diameter/body surface area). Women also more frequently had associated chronic obstructive pulmonary disease but less frequently CAD. Another key point is that women were more likely to be symptomatic at presentation and consequently to undergo urgent/emergent procedures more frequently. Postoperatively, women had increased median hospital and intensive care unit lengths of stay. The authors concluded that, even after adjusting for differences in age and comorbidities, female patients have higher perioperative mortality and lower longterm survival after TEVAR. These findings, along with the higher rupture risk reported in women, emphasise the need for a more precise definition of the timing of intervention, particularly for women (Table 2) .
Screening programmes for aortic aneurysms
Screening programmes for aortic aneurysms basically cover AAAs. In fact, evidence from randomised trials has shown that, in men, screening is effective in reducing AAA-related mortality and is cost-effective. 62, 63 The majority of screening programmes recommend a single ultrasound scan for men aged 65 years, irrespective of medical history or risk factors. However, the incidence of AAAs in the US Veterans' Administration USVA programme, in which only previous or current smokers underwent screening, is over 7%. 64 On the other hand, there is no clinical trial evidence on the efficacy of screening on high-risk male subgroups over the age of 65 years, and there is currently no consensus on the role of screening for AAAs in women. To date, the only randomised trial of screening in women, which was small and underpowered, demonstrated no mortality benefit. 65 Doubts related to the inefficacy of a screening programme arise because of Table 2 . Gender and thoracic aortic aneurysms.
Highlights
Patients with TAAs tend less frequently to havea history of smoking, associated coronary artery disease, chronic lung disease, and diabetes than patients affected by abdominal aortic aneurysms. Degenerative aneurysm is generally detected in the sixth and seventh decade of life, with women typically older than men. TAAs are more prevalent in men, although the prognosis is worse in women, in terms of severe incidence of dissection or rupture, and significantly higher mortality, even at smaller diameter. Sex-specific predictors for operative mortality, including urgent or emergency repair, are: 1. For men: chronic renal insufficiency, and previous stroke. 2. For women: the presence of any symptoms or having an extent II or III TAA repair, aneurysm without dissection, previous open distal aortic repair, and a history of chronic obstructive pulmonary disease, emphysema, or bronchitis.
TAA: thoracic aortic aneurysm.
the lower prevalence of AAA in women. Moreover, it remains a matter of debate whether early detection of AAA in women allows a significant improvement in the length and quality of life. In fact, it is well known that women experience AAA rupture earlier than men and have worse outcomes after AAA surgery. 36, [66] [67] [68] The risk related to surgical treatment is an important determinant of the effectiveness of any AAA screening programme. Worse outcomes in women may balance out any advantage obtained by a 'preventing rupture' scheme study, with a potential negative impact on the cost-effectiveness of screening programmes to identify women with AAA. 29 Finally, many of the studies designed to compare the risks of surgery between men and women are not recent, and the usefulness of their results is limited by the low percentage of women enrolled in studies of AAAs.
Further considerations, however, require discussion. The prevalence of AAA in female smokers is around 2%, 69 and health economic studies of male AAA screening demonstrated cost-effectiveness at much lower prevalence rates, 63 despite reductions in disease prevalence. 70, 71 Finally, considering that the prevalence threshold for cost-effectiveness in screening programmes in men is lower than the estimates of disease prevalence reported in older women, 72 it would seem intuitive that targeting female smokers or selected highrisk groups of women might be cost-effective.
Given the discussions about the cost-effectiveness of nationwide screening programmes, it has been suggested that screening for aneurysms in family members of AAA patients may be a valuable alternative to screening in the general population, although there are diverging recommendations in the aneurysm guidelines. The American College of Cardiology (ACC)/ American Heart Association (AHA) guideline recommends screening of only male relatives, 73 whereas the European Society for Vascular Surgery guideline stresses the need for screening of all relatives in the case of a documented family history of AAAs. 74 There are recent studies that suggest focusing on AAA risk for female relatives and relatives of female AAA patients, or supporting targeted family screening of all (first-degree) relatives of all AAA patients, irrespective of sex. 40 
Conclusions and future directions
Female patients affected by aortic disease have still worse outcomes and higher early and late mortality than men. It is difficult to plan new specific strategies to improve outcomes in women undergoing major aortic surgery, given that the true explanations for their poorer outcomes are as yet not clearly identified. The first step is the treatment of patients classified as high risk, which could be optimised before surgery becomes necessary by means of numerous strategies, such as the administration of high-dose statin therapy, antiplatelet treatment, optimal control of hypertension, lifestyle improvement with smoking cessation, weight loss and careful control of diabetes. The second step is the improvement of experimental and clinical research in the field of endograft technology, which will allow a wide and safe use of both EVAR and TEVAR in female patients in the near future (Table 3) .
Future efforts are needed to understand better gender differences in the diagnosis, management and outcome of aortic aneurysm disease, and for appropriate and modern management of female patients. Table 3 . Take home messages.
Screening programmes for aortic aneurysms basically cover AAAs. There is no clinical trial evidence on the efficacy of screening on high-risk male subgroups over the age of 65 years. There is currently no consensus on the role of screening for AAAs in women. To date, the only randomised trial of screening in women, which was small and underpowered, demonstrated no mortality benefit. Doubts related to the inefficacy of a screening programme arise because of the lower prevalence of AAAs in women. Screening for aneurysms in family members of AAA patients may be a valuable alternative to screening in the general population, although there are diverging recommendations in the aneurysm guidelines. Optimisation of the treatment of high-risk patients involves numerous strategies, such as the administration of high-dose statin therapy, antiplatelet treatment, optimal control of hypertension, lifestyle improvement with smoking cessation, weight loss and careful control of diabetes. It is fundamental to improve experimental and clinical research in the field of endograft technology, which will allow a wide and safe use of both EVAR and TEVAR in female patients in the near future.
AAA: abdominal aortic aneurysm; EVAR: endovascular aneurysm repair; TEVAR: thoracic endovascular aortic aneurysm repair.
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